SCHEMBL372352

SCHEMBL372352

CCn1cc[n+](C)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 1/20 0.38
APAF1 O14727 1/20 0.38
NPC1 O15118 1/20 0.38
PLA2G1B P04054 1/20 0.38
HSP90AA1 P07900 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ATG4B Q9Y4P1 1/20 0.38
FDPS P14324 3/20 0.35
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29434929 1.00 SMN1; SMN2 (0.38) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Lithium SCHEMBL29973484 0.98 SMN1; SMN2 (0.37) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
SCHEMBL8080635 0.91 SMN1; SMN2 (0.36) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Trifluoroacetic Acid SCHEMBL460210 0.91 FDPS (0.36) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
SCHEMBL29395782 0.88 SMN1; SMN2 (0.46) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
SCHEMBL2934584 0.86 FDPS (0.40) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
SCHEMBL29450332 0.85 MEN1 (0.55) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
SCHEMBL625417 0.85 MEN1 (0.55) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Trifluoromethanesulfonic Acid SCHEMBL133213 0.84 FDPS (0.40) SMN1; SMN2MEN1APAF1NPC1PLA2G1B
Trifluoromethanesulfonamide SCHEMBL5168110 0.84 SMN1; SMN2 (0.40) SMN1; SMN2MEN1APAF1NPC1PLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 962 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121584028-B Electrolyte for improving ultralow temperature performance of lithium iron phosphate battery and battery JILIN UNIVERSITY (CN) 2026-05-26 CN claimed
WO-2026106151-A1 POLYMER COMPOSITE BINDER FOR LITHIUM SECONDARY BATTERY ELECTRODE MIXTURE AND LITHIUM SECONDARY BATTERY INCLUDING SAME 주식회사 유뱃 2026-05-21 WO claimed
WO-2026107437-A1 SYNERGY OF A COMPLEMENTARY IONIC BIOGEL NETWORK FOR NEUROHAPTICS THE PENN STATE RESEARCH FOUNDATION (US) 2026-05-21 WO claimed
CN-121005385-B Lithium ion solid electrolyte material yttrium lithium sodium phosphate and preparation method and application thereof 中国科学院上海硅酸盐研究所 2026-05-12 CN claimed
US-12625298-B2 Method of manufacture of a metasurface Max Planck Gesellschaft Zur Förderung Der Wissenschaften eV (DE) 2026-05-12 US claimed
EP-4465379-B1 POSITIVE ELECTRODE FOR SOLID-STATE BATTERIES AND SOLID-STATE BATTERIES COMPRISING THE SAME FUND CIDETEC (ES) 2026-05-06 EP claimed
US-20260121174-A1 High Power and High Energy Supercapbattery Device and Method of Making Same RAM MANOJ KUMAR (US) 2026-04-30 US claimed
US-20260103625-A1 ADHESIVE COMPOUND, ADHESIVE TAPE, BONDED COMPOSITE, AND METHOD FOR ELECTRICALLY DEBONDING THE BONDED COMPOSITE TESA SE (DE) 2026-04-16 US claimed
US-12586820-B2 Electrolyte for lithium secondary batteries comprising ionic liquid and cosolvent and lithium secondary battery comprising the same HYUNDAI MOTOR COMPANY (KR) 2026-03-24 US claimed
US-20260051533-A1 ANODE SUPPORTED SOLID-STATE ELECTROLYTE SEPARATORS GM GLOBAL TECH OPERATIONS LLC (US) 2026-02-19 US claimed
EP-1883616-A1 A PROCESS FOR CONTINUOUS CARBONYLATION BY SUPPORTED IONIC LIQUID-PHASE CATALYSIS Danmarks Tekniske Universitet (DK) 2008-02-06 EP claimed
US-20080011606-A1 Voltammetric Ion Sensor ROCHE DIAGNOSTICS OPERATIONS, INC. 2008-01-17 US claimed
US-7242134-B2 Electromechanical actuator and methods of providing same UNIVERSITY OF WOLLONGONG (AU) 2007-07-10 US claimed
EP-1800116-A1 VOLTAMMETRIC ION SENSOR Oxford Biosensors Limited (GB) 2007-06-27 EP claimed
WO-2006122563-A1 A PROCESS FOR CONTINUOUS CARBONYLATION BY SUPPORTED IONIC LIQUID-PHASE CATALYSIS DANMARKS TEKNISKE UNIVERSITET (DK) 2006-11-23 WO claimed
WO-2006040588-A1 VOLTAMMETRIC ION SENSOR OXFORD BIOSENSORS LIMITED (GB) 2006-04-20 WO claimed
US-20050205493-A1 Ionic liquids as solvents in headspace gas chromatography NOVARTIS AG (CH) 2005-09-22 US claimed
EP-1529205-A2 ANALYTICAL PROCESS Novartis AG (CH) 2005-05-11 EP claimed
US-20050006989-A1 Electromechanical actuator and methods of providing same UNIVESITY OF WOLLONGONG (AU) 2005-01-13 US claimed
WO-2004013612-A2 IONIC LIQUIDS AS SOLVENTS IN HEADSPACE GAS CHROMATOGRAPHY NOVARTIS AG (CH) 2004-02-12 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260103625-A1 ADHESIVE COMPOUND, ADHESIVE TAPE, BONDED COMPOSITE, AND METHOD FOR ELECTRICALLY DEBONDING THE BONDED COMPOSITE AFF2, AFF1, AFF4 SMN1; SMN2 542/4885MEN1 4167/4885APAF1 1688/4885
US-20260121174-A1 High Power and High Energy Supercapbattery Device and Method of Making Same SOS2, RPSA, SUDS3 SMN1; SMN2 588/4885MEN1 3279/4885APAF1 4118/4885
US-12586820-B2 Electrolyte for lithium secondary batteries comprising ionic liquid and cosolvent and lithium secondary battery comprising the same CACNA1I, CCNI, NSD3 SMN1; SMN2 354/4885MEN1 731/4885APAF1 2277/4885
US-12625298-B2 Method of manufacture of a metasurface AXIN2, FOXM1, FOXO1 SMN1; SMN2 3706/4885MEN1 415/4885APAF1 3217/4885
US-20260051533-A1 ANODE SUPPORTED SOLID-STATE ELECTROLYTE SEPARATORS XPO4, XPA, CACNA2D4 SMN1; SMN2 831/4885MEN1 370/4885APAF1 2310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.